1.0MedCity INVEST PharmaTechhttps://events.medcitynews.com/invest-pharmatechLaura Kittredgehttps://events.medcitynews.com/invest-pharmatech/author/lkittredge/Pierre Leurent - MedCity INVEST PharmaTechrich600338<blockquote class="wp-embedded-content" data-secret="C3M3KSU4re"><a href="https://events.medcitynews.com/invest-pharmatech/speakers/pierre-leurent/">Pierre Leurent</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://events.medcitynews.com/invest-pharmatech/speakers/pierre-leurent/embed/#?secret=C3M3KSU4re" width="600" height="338" title="“Pierre Leurent” — MedCity INVEST PharmaTech" data-secret="C3M3KSU4re" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script type="text/javascript">
/* <![CDATA[ */
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
//# sourceURL=https://events.medcitynews.com/invest-pharmatech/wp-includes/js/wp-embed.min.js
/* ]]> */
</script>
https://events.medcitynews.com/uploads/sites/3/2022/04/Pierre.jpg13591359Pierre Leurent, CEO and co-founder of Voluntis, an Aptar Pharma company, has over 20 years of experience in digital health in the United States and Europe. Prior to starting Voluntis, Pierre worked at GE Medical Systems in its medical imaging software division, and at HealthCenter Internet Services, a vendor of Electronic Medical Record solutions based…